# Gait stability in peripheral artery disease: a phase-dependent analysis using gait tube methodology

**Authors:** Arash Mohammadzadeh Gonabadi, Iraklis I. Pipinos, Sara A. Myers, Farahnaz Fallahtafti

PMC · DOI: 10.3389/fresc.2026.1725201 · Frontiers in Rehabilitation Sciences · 2026-02-12

## TL;DR

This study shows that people with peripheral artery disease have specific gait instability patterns that can be detected using a new 3D analysis method.

## Contribution

The study introduces phase-dependent gait tube stability analysis to detect PAD-specific gait deficits missed by traditional metrics.

## Key findings

- PAD patients had significantly lower ellipsoid volumes and vertical variability compared to controls.
- Gait instability in PAD was most pronounced during weight acceptance and early stance phases.
- PAD showed impaired multidirectional coordination with weak correlations between stability metrics.

## Abstract

Peripheral Artery Disease (PAD) affects over eight million U.S. adults, impairing mobility, quality of life, and increasing fall and cardiovascular risks. PAD reduces lower limb blood flow and contributes to neuromuscular dysfunction, leading to unstable gait. Traditional stability metrics often miss phase-specific changes. Gait Tube Stability (GTS) is a phase-dependent, three-dimensional method that analyzes center of mass (COM) velocity using ellipsoidal variability to detect directional instability. This study examined whether GTS can identify phase-specific gait deficits in PAD compared with age-matched controls.

Fifty-two PAD patients and 132 healthy individuals walked on a force-instrumented treadmill at self-selected speeds. GTS metrics-including ellipsoid volume and direction-specific variabilities (AP, ML, VT)-were computed from 3D COM velocity. Data were segmented by gait phase and analyzed using Wilcoxon rank-sum tests and Statistical Parametric Mapping (SPM).

PAD patients exhibited significantly lower ellipsoid volumes (3.07 × 105 mm³/s³, p < 0.001) and reduced VT variability (40.29 mm/s, p < 0.001) compared to controls (1.02 × 106 mm³/s³ and 93.60 mm/s). No significant differences were found in AP (p = 0.1062) or ML (p = 0.6467) variability. Correlation between ellipsoid volume and total variability was weak in PAD (r = 0.06, p = 0.6587) but moderate in controls (r = 0.55, p < 0.001), indicating impaired multidirectional coordination in PAD. Correlation analysis revealed a significant association between ellipsoid volume and total variability in controls but not in PAD, and Fisher's r-to-z test confirmed a significant between-group difference (p = 0.005).

GTS revealed phase-specific gait deficits in PAD, especially during weight acceptance and early stance, indicating a constrained, energy-conserving strategy that may elevate fall risk. By detecting critical instability phases, GTS can guide targeted physical therapy, assistive device use, and optimal timing for robotic or exoskeleton support-supporting personalized interventions and offering a sensitive tool for clinical gait stability assessment.

## Linked entities

- **Diseases:** PAD (MONDO:0005386)

## Full-text entities

- **Diseases:** cramping (MESH:D009120), sensory-motor nerve dysfunction (MESH:D005155), postural disturbances (MESH:D054972), diminished quality of life (MESH:D003643), impaired direction coordination (MESH:D001259), hypertension (MESH:D006973), atherosclerotic (MESH:D050197), vascular (MESH:D057772), PAD (MESH:D058729), muscular dysfunction (MESH:D009135), thromboembolic disease (MESH:D013923), MS (MESH:D009103), GTS (MESH:D043171), impaired neuromuscular function (MESH:D009468), tissue loss (MESH:D017695), unstable (MESH:D000789), traumatic injuries (MESH:D014947), balance loss (MESH:D016388), dyslipidemia (MESH:D050171), leg pain (MESH:D010146), Fontaine (MESH:C536311), deficits in strength, proprioception, and coordination (MESH:D020886), lower-limb muscle weakness (MESH:D018908), ischemic (MESH:D002545), diabetes (MESH:D003920), vascular and sensory deficits (MESH:D012678), vascular insufficiency (MESH:D065666), gait deficits (MESH:D020233), falls (MESH:C537863), VT (MESH:D009759), fatigue (MESH:D005221), COPD (MESH:D029424), ischemia (MESH:D007511), COM (MESH:C536030), skeletal muscle myopathy (MESH:D005207), Intermittent claudication (MESH:D007383)
- **Chemicals:** oxygen (MESH:D010100)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12935866/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12935866/full.md

## References

68 references — full list in the complete paper: https://tomesphere.com/paper/PMC12935866/full.md

---
Source: https://tomesphere.com/paper/PMC12935866